Insider · CIK 0001498992
Kenneth A Burdick
director
Files at CNC (CENTENE CORP), LFST (LifeStance Health Group, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 10, 2025 | LFST LifeStance Health Group, Inc. | FTax withholding Common Stock | -35,817 | $7.11 | $255k | 3,368,901 | May 19, 2025 |
| May 13, 2025 | CNC CENTENE CORP | AGrant or award Common Stock | +3,579 | $0.00 | $0 | 366,497 | May 14, 2025 |
| Mar 31, 2025 | CNC CENTENE CORP | AGrant or award Common Stock | +500 | $0.00 | $0 | 362,918 | Apr 2, 2025 |
| Mar 6, 2025 | LFST LifeStance Health Group, Inc. | AGrant or award Common Stock | +95,178 | $0.00 | $0 | 3,029,550 | Mar 10, 2025 |
| Mar 6, 2025 | LFST LifeStance Health Group, Inc. | FTax withholding Common Stock | -53,602 | $7.88 | $422k | 2,975,948 | Mar 10, 2025 |
| Mar 7, 2025 | LFST LifeStance Health Group, Inc. | AGrant or award Common Stock | +283,172 | $0.00 | $0 | 3,259,120 | Mar 10, 2025 |
| Mar 7, 2025 | LFST LifeStance Health Group, Inc. | FTax withholding Common Stock | -111,430 | $7.59 | $846k | 3,147,690 | Mar 10, 2025 |
| Mar 7, 2025 | LFST LifeStance Health Group, Inc. | AGrant or award Common Stock | +423,790 | $0.00 | $0 | 3,571,480 | Mar 10, 2025 |
| Mar 7, 2025 | LFST LifeStance Health Group, Inc. | FTax withholding Common Stock | -166,762 | $7.59 | $1.3M | 3,404,718 | Mar 10, 2025 |
| Dec 31, 2024 | CNC CENTENE CORP | AGrant or award Common Stock | +497 | $0.00 | $0 | 362,418 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.